Harare — More than 1,3-million Zimbabweans living with HIV/Aids are at risk as the cash-strapped government battles to raise $6m needed to unlock $400m in donor funding for antiretroviral (ARV) drugs.

The southern African nation is facing critical shortages of medicines and patients are being asked to pay for their prescriptions in hard currency. The elite and top government officials are seeking medical treatment abroad to avoid the country's dire health services. 

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now